US Pharma MarketingSanofi spells out asthma data, AstraZeneca details COPD win at #ERS26
Sanofi, AstraZeneca, Upstream Bio and GSK detail fresh respiratory trial data at ERS for lunsekimig, tozorakimab, verekitug and Nucala. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo…
During this year’s European Respiratory Society (ERS) annual meeting in Barcelona, companies such as Sanofi and AstraZeneca lifted the curtain on detailed results from trials they had previously called a success. Upstream Bio and GSK ...
Source: Endpoints News